Visium Asset Management’s Chemours CC Stock Holding History

Visium Asset Management’s Portfolio CC Stock Details CC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-18,770	Closed	-$155K	–	36
2016 Q2	$155K	Sell	18,770 -543,696	-97%	-$4.84M	0.01%	326
2016 Q1	$3.94M	Buy	+562,466	New	+$2.83M	0.07%	304
2015 Q4	–	Sell	-39,690	Closed	-$257K	–	621
2015 Q3	$257K	Buy	+39,690	New	+$415K	﹤0.01%	724

Other funds holding CC

Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return

GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GCM

Gates Capital Management New York $3.66B AUM 12.63% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Visium Asset Management's CC Position: Q3 2016 in Review

Visium Asset Management sold out of Chemours (CC) in Q3 2016, closing a stake of 18,770 shares — an estimated $155K sold.

Visium Asset Management first reported a position in CC in Q3 2015 and held it in 3 quarters. The position peaked at $3.94M in Q1 2016. 378 funds tracked by Wall St. Rank hold CC as of Q3 2016.

Visium Asset Management reported no remaining Chemours position as of Q3 2016 after selling out during the quarter.
Visium Asset Management sold 18,770 Chemours shares in Q3 2016, an estimated $155K.
Visium Asset Management first reported a position in Chemours in Q3 2015 and held it in 3 quarters.
Visium Asset Management's Chemours position peaked at $3.94M in Q1 2016.
378 funds tracked by Wall St. Rank held Chemours as of Q3 2016.

Based on Visium Asset Management's 13F filing for Q3 2016.